Program Description
Allergic conjunctivitis is one of the most common conditions affecting eye health for which patients seek self-care options. Various over-the-counter (OTC) ophthalmic treatment options are available in the pharmacy to achieve symptom control, and pharmacists and pharmacy technicians should be familiar with the different classes including antihistamines, mast cell stabilizers, dual-activity agents, and nonsteroidal anti-inflammatory drugs (NSAIDs). Despite the OTC availability of treatment options, patients with allergic conjunctivitis are commonly underdiagnosed and undertreated. With a multitude of OTC ophthalmic treatments, pharmacists have a fundamental role in the identification of allergic conjunctivitis and recommendation of evidence-based treatments. This activity will establish foundational knowledge of allergic conjunctivitis and treatment options for pharmacy technicians and information to prepare pharmacists to effectively educate patients about its symptoms and patient self-management strategies to prevent ocular complications. Patient counseling video vignettes will supplement the activity by providing key highlights and tips for optimal patient interactions.
Target audience: Retail pharmacists
Activity type: Application for pharmacists
Release date: October 31, 2022
Expiration date: October 31, 2023
Estimated time to complete activity: 2.0 hours
Fee: Free
Educational Objectives
At the completion of this activity, the pharmacist will be able to:
- Express the prevalence of allergic conjunctivitis (AC) and burden of associated symptoms for patients
- Personalize management strategies with available therapies for patients with AC based on current data
- Show patients OTC strategies to optimize self-management of AC and prevent associated complications
Jason Zupec, PharmD, BCACP
Associate Professor of Clinical Pharmacy
Philadelphia College of Pharmacy at Saint Joseph’s University
Philadelphia, Pennsylvania
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity numbers 0290-0000-22-503-H01-P and 0290-0000-22-504-H01-T. The activity is available for CE credit through October 31, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, listen to the podcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Jason Zupec, PharmD, BCACP
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Rose Namissa-Buszka, PharmD, BCPS, CHCP; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta
Pharmacy Times® Editorial Staff—Davy James
Medical reviewer Kaelen Dunican, PharmD, has the following financial relationships with commercial interests to disclose:
Advisory Board: Johnson & Johnson Consumer
Inc, PMAC
An anonymous peer reviewer was part of the content validation and conflict resolution and has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms